During a debate at the American Diabetes Association Scientific Sessions, Amy M. Valent, D.O., says identifying gestational diabetes and treating it, and the quality of carbohydrates in one’s diet, improves perinatal outcomes. She says, "The primary target for people with gestational diabetes has been dietary, and that approach has been low carbohydrates, which has been able to decrease perinatal mortality to the level that we are at today.”

Gordon Mills, M.D., Ph.D., will participate in a key opinion leader meeting o.n two clinical-stage drug candidates

In a Nature News article on research to “outwit” cancer’s evasion tactics, work co-led by Joe Gray, Ph.D., is mentioned as an effective way to test up to 18 drug combinations simultaneously within different regions of a single tumor, capturing a more detailed and naturalistic view of the efficacy and mechanism of action for these therapies.

George Keepers, M.D., explains to Everyday Health the difference between biolar disorder and schizoaffective disorder: “In bipolar disorder, delusions only occur during an active manic or depressive phase, while in schizoaffective disorder, psychosis can happen outside active mood phases.”

Alyssa Colwill, M.D., discusses OHSU's program to train out-of-state OB/GYN residents in abortion services after their states ban the procedure. She says, "We decided that we had the bandwidth and opportunity to train more individuals that were going to lose access to services and educational opportunities."

KATU-TV covers the ONA announcement of a strike vote.

A new study, led by scientists at Oregon Health & Science University and published online in the journal Annals of Neurology on Aug. 21, reveals for the first time that a form of cell death known as ferroptosis -; caused by a buildup of iron in cells -; destroys microglia cells, a type of cell involved in the brain's immune response, in cases of Alzheimer's and vascular dementia.

A new study reveals for the first time a new avenue of cell death in Alzheimer’s disease and vascular dementia. “Everyone knows that microglia are activated to mediate inflammation,” says Stephen Back, M.D., Ph.D. “But no one knew that they were dying in such large numbers. It’s just amazing that we missed this until now.”

A new study reveals for the first time a new avenue of cell death in Alzheimer’s disease and vascular dementia. “Everyone knows that microglia are activated to mediate inflammation,” says Stephen Back, M.D., Ph.D. “But no one knew that they were dying in such large numbers. It’s just amazing that we missed this until now.”